Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Mar-24 5:32 PM View:  | Johnson John H Director | Xeris Biopharma Holdings, I... (XERS) | 18-Mar-24 | Option Exercise | 215,600 | $1.99 | $429,044.00 | 40% 535.81K to 751.41K | |
| 11-Apr-24 4:05 PM View: | Sherman Jeffrey W Director | Xeris Biopharma Holdings, I... (XERS) | 15-Mar-24 | Acquisition (other) | 6,502 | -- | -- | 6% 113.28K to 119.78K | |
| 01-Apr-24 5:43 PM View: | Johnson John H Director | Xeris Biopharma Holdings, I... (XERS) | 15-Mar-24 | Acquisition (other) | 89,571 | -- | -- | 12% 751.41K to 840.98K | |
| 01-Apr-24 5:45 PM View: | Kong Garheng Director | Xeris Biopharma Holdings, I... (XERS) | 15-Mar-24 | Acquisition (other) | 6,474 | -- | -- | 6% 107.67K to 114.14K | |
| 14-Mar-24 9:03 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 14-Mar-24 | Private Purchase | 4,500 | $2.16 | $9,720.00 | 6% 69.66K to 74.16K | |
| 31-Jan-24 5:04 PM View: | Hecht Beth See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 750,000 | -- | -- | 93% 804.97K to 1.55M | |
| 31-Jan-24 5:05 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 450,000 | -- | -- | 38% 1.18M to 1.63M | |
| 31-Jan-24 5:05 PM View: | Shannon John Patrick Jr See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 750,000 | -- | -- | 53% 1.41M to 2.16M | |
| 31-Jan-24 5:04 PM View: | Johnson Kenneth Erland See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 175,000 | -- | -- | 64% 271.86K to 446.86K | |
| 31-Jan-24 5:04 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 1,500,000 | -- | -- | 65% 2.32M to 3.82M | |
| 29-Nov-23 4:09 PM View: | Sherman Jeffrey W Director | Xeris Biopharma Holdings, I... (XERS) | 27-Nov-23 | Private Purchase | 5,400 | $1.87 | $10,098.00 | 5% 107.88K to 113.28K | |
| 21-Nov-23 4:20 PM View: | Halkuff Dawn Director | Xeris Biopharma Holdings, I... (XERS) | 20-Nov-23 | Private Purchase | 5,410 | $1.84 | $9,954.40 | 9% 57.5K to 62.91K | |
| 21-Nov-23 4:16 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 20-Nov-23 | Private Purchase | 28,000 | $1.95 | $54,600.00 | 2% 1.15M to 1.18M | |
| 17-Nov-23 5:58 PM View: | Shannon John Patrick Jr See Remarks | Xeris Biopharma Holdings, I... (XERS) | 17-Nov-23 | Private Purchase | 30,769 | $1.64 | $50,399.60 | 2% 1.38M to 1.41M | |
| 17-Nov-23 6:35 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 16-Nov-23 | Private Purchase | 6,500 | $1.51 | $9,815.00 | 10% 63.16K to 69.66K | |
| 15-Nov-23 4:13 PM View: | Persky Marla Director | Xeris Biopharma Holdings, I... (XERS) | 14-Nov-23 | Private Purchase | 6,370 | $1.58 | $10,057.60 | 11% 57.5K to 63.87K | |
| 09-Aug-23 6:57 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 09-Aug-23 | Market Purchase | 10,000 | $2.38 | $23,794.00 | < 1% 2.31M to 2.32M | 3% |
| 07-Jun-23 4:55 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 206% 20.66K to 63.16K | |
| 07-Jun-23 4:58 PM View: | Halkuff Dawn Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 283% 15.0K to 57.5K | |
| 07-Jun-23 5:00 PM View: | Kong Garheng Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 65% 65.17K to 107.67K | |
| 07-Jun-23 4:52 PM View: | Sherman Jeffrey W Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 65% 65.38K to 107.88K | |
| 07-Jun-23 5:02 PM View: | Bormann-Kennedy Barbara-Jea... Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 283% 15.0K to 57.5K | |
| 07-Jun-23 4:59 PM View: | Johnson John H Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 9% 493.31K to 535.81K | |
| 07-Jun-23 4:56 PM View: | Persky Marla Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 283% 15.0K to 57.5K | |
| 29-Mar-23 4:53 PM View: | Fairley Ricki Louise Director | Xeris Biopharma Holdings, I... (XERS) | 27-Mar-23 | Grant | 85,000 | -- | -- | 100% 0 to 85.0K | |
| 01-Feb-23 4:12 PM View: | Johnson Kenneth Erland See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 100,000 | -- | -- | 59% 169.78K to 269.78K | |
| 01-Feb-23 4:13 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 750,000 | -- | -- | 48% 1.56M to 2.31M | |
| 01-Feb-23 4:13 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 750,000 | -- | -- | 188% 398.91K to 1.15M | |
| 01-Feb-23 4:13 PM View: | Shannon John Patrick Jr See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 750,000 | -- | -- | 119% 627.81K to 1.38M | |
| 01-Feb-23 4:12 PM View: | Hecht Beth See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 350,000 | -- | -- | 78% 447.76K to 797.76K | |
| 01-Feb-23 4:12 PM View: | Prestrelski Steven Chief Scientific Officer | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 150,000 | -- | -- | 26% 569.78K to 719.78K | |
| 14-Dec-22 4:11 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 13-Dec-22 | Private Purchase | 20,000 | $1.45 | $29,000.00 | 1% 1.54M to 1.56M | |
| 09-Jun-22 5:15 PM View: | Sherman Jeffrey W Director | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | -- | -- | 30% 50.38K to 65.38K | |
| 09-Jun-22 5:15 PM View: | Bormann-Kennedy Barbara-Jea... Director | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | $2.10 | $31,500.00 | 100% 0 to 15.0K | |
| 09-Jun-22 5:13 PM View: | Johnson John H Director | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | -- | -- | 3% 478.31K to 493.31K | |
| 09-Jun-22 5:14 PM View: | Persky Marla Director | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 09-Jun-22 5:13 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | -- | -- | 265% 5.66K to 20.66K | |
| 09-Jun-22 5:14 PM View: | Halkuff Dawn Director | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 09-Jun-22 7:05 PM View: | Kong Garheng Director | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | -- | -- | 30% 50.17K to 65.17K | |
| 13-May-22 4:19 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 12-May-22 | Private Purchase | 100,000 | $1.40 | $140,380.00 | 7% 1.44M to 1.54M | |
| 24-Feb-22 4:28 PM View: | Prestrelski Steven Chief Scientific Officer | Xeris Biopharma Holdings, I... (XERS) | 22-Feb-22 | Option Exercise | 11,228 | $0.69 | $7,747.32 | 2% 569.78K to 581.01K | |
| 24-Feb-22 4:28 PM View: | Prestrelski Steven Chief Scientific Officer | Xeris Biopharma Holdings, I... (XERS) | 22-Feb-22 | Planned Option Sale | 11,228 | $2.42 | $27,158.30 | (2%) 581.01K to 569.78K | |
| 05-Jan-22 6:16 PM View: | Hecht Beth See Remarks | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-22 | Grant | 225,000 | -- | -- | 106% 211.82K to 436.82K | |
| 05-Jan-22 6:16 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-22 | Grant | 600,000 | -- | -- | 71% 841.49K to 1.44M | |
| 05-Jan-22 6:16 PM View: | Shannon John Patrick Jr See Remarks | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-22 | Grant | 250,000 | -- | -- | 68% 368.91K to 618.91K | |
| 05-Jan-22 6:17 PM View: | Johnson Kenneth Erland See Remarks | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-22 | Grant | 75,000 | -- | -- | 83% 90.86K to 165.87K | |
| 05-Jan-22 6:15 PM View: | Prestrelski Steven Chief Scientific Officer | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-22 | Grant | 75,000 | -- | -- | 15% 494.78K to 569.78K | |
| 05-Jan-22 7:03 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-22 | Grant | 200,000 | -- | -- | 106% 188.83K to 388.83K | |
| 16-Nov-21 4:25 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 15-Nov-21 | Market Purchase | 20,000 | $2.28 | $45,664.00 | 2% 821.49K to 841.49K | 9% |
| 12-Nov-21 5:12 PM View: | Shannon John Patrick Jr See Remarks | Xeris Biopharma Holdings, I... (XERS) | 12-Nov-21 | Market Purchase | 60,000 | $2.10 | $126,000.00 | 20% 303.83K to 363.83K | (< 1%) |
